Stay updated on ImPRESS: Losartan Imaging Perfusion Clinical Trial
Sign up to get notified when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.

Latest updates to the ImPRESS: Losartan Imaging Perfusion Clinical Trial page
- Check3 days agoChange DetectedThe study page now displays a 403 Forbidden error, indicating the record cannot be accessed. The visible site chrome remains, but the main content is blocked, signaling an access permissions issue rather than a content update.SummaryDifference21%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now includes a 2018 NIH grant/contract note and updates the Revision to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page footer's revision label updated from v3.6.4 to v3.6.5, indicating a version increment of the site's backend/template. This change does not alter the visible content of the study page.SummaryDifference0.0%

- Check52 days agoChange DetectedAffiliation details were updated to streamline the institution name in the Locations section, replacing 'Oslo University Hospital, Oslo, Norway' with 'Oslo University Hospital.' The related publication citation was updated to reflect the final Jun 2026 publication date, replacing the earlier 'Online ahead of print' entry.SummaryDifference0.1%

- Check60 days agoChange DetectedFooter text updated to Revision: v3.6.4, indicating a new build/version of the page. The change does not alter study information or page layout beyond the version label.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page revision has been updated to v3.6.3, indicating a new edition of the study record. The change appears to be metadata-related and does not modify the study details or required actions.SummaryDifference0.0%

Stay in the know with updates to ImPRESS: Losartan Imaging Perfusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.